Jay R. Luly

Enanta Pharmaceuticals

President and Chief Executive Officer

Overview

Jay R. Luly made an average of $2.7M in compensation at Enanta Pharmaceuticals from 2011 to 2018.

Annual data

2018

In 2018, Jay R. Luly earned a total compensation of $4.5M as President and Chief Executive Officer at Enanta Pharmaceuticals.

Ranking1,658 out of 9,013
Percentile81.6%

Jay R. Luly's 2018 compensation ranked 1,658th out of 9,013 executive pay records tracked by us this year.

Luly earned more than 81.6% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking113 out of 694
Percentile83.7%

In the industry group of Drugs, Luly's pay ranked 113th out of 694 executive pay records tracked by us in 2018.

Luly earned more than 83.7% of executives in this group.

Non-Equity Incentive Plan$355,688
Option Awards$2,684,490
Salary$611,178
Stock Awards$838,530
Other$18,851
Total$4,508,737

Luly received $2.7M in option awards, which accounts for 59.54% of total compensation.

Luly also received $355.7K in non-equity incentive plan, $611.2K in salary, $838.5K in stock awards and $18.9K in other compensation.

2017

In 2017, Jay R. Luly earned a total compensation of $4.3M as President and Chief Executive Officer at Enanta Pharmaceuticals.

Ranking2,152 out of 13,282
Percentile83.8%

Jay R. Luly's 2017 compensation ranked 2,152nd out of 13,282 executive pay records tracked by us this year.

Luly earned more than 83.8% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking142 out of 1,427
Percentile90.0%

In the industry group of Drugs, Luly's pay ranked 142nd out of 1,427 executive pay records tracked by us in 2017.

Luly earned more than 90.0% of executives in this group.

Non-Equity Incentive Plan$345,648
Option Awards$2,055,720
Salary$581,203
Stock Awards$1,279,980
Other$18,551
Total$4,281,102

Luly received $2.1M in option awards, which accounts for 48.02% of total compensation.

Luly also received $345.6K in non-equity incentive plan, $581.2K in salary, $1.3M in stock awards and $18.6K in other compensation.

2016

In 2016, Jay R. Luly earned a total compensation of $3.5M as President and Chief Executive Officer at Enanta Pharmaceuticals.

Ranking2,650 out of 13,896
Percentile80.9%

Jay R. Luly's 2016 compensation ranked 2,650th out of 13,896 executive pay records tracked by us this year.

Luly earned more than 80.9% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking185 out of 1,477
Percentile87.5%

In the industry group of Drugs, Luly's pay ranked 185th out of 1,477 executive pay records tracked by us in 2016.

Luly earned more than 87.5% of executives in this group.

Non-Equity Incentive Plan$309,585
Option Awards$2,182,686
Salary$542,393
Stock Awards$404,953
Other$15,857
Total$3,455,474

Luly received $2.2M in option awards, which accounts for 63.17% of total compensation.

Luly also received $309.6K in non-equity incentive plan, $542.4K in salary, $405K in stock awards and $15.9K in other compensation.

2015

In 2015, Jay R. Luly earned a total compensation of $3.6M as President and Chief Executive Officer at Enanta Pharmaceuticals.

Ranking2,532 out of 13,574
Percentile81.3%

Jay R. Luly's 2015 compensation ranked 2,532nd out of 13,574 executive pay records tracked by us this year.

Luly earned more than 81.3% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking250 out of 1,484
Percentile83.2%

In the industry group of Drugs, Luly's pay ranked 250th out of 1,484 executive pay records tracked by us in 2015.

Luly earned more than 83.2% of executives in this group.

Bonus$286,411
Option Awards$2,518,566
Salary$520,748
Stock Awards$225,335
Other$15,706
Total$3,566,766

Luly received $2.5M in option awards, which accounts for 70.61% of total compensation.

Luly also received $286.4K in bonus, $520.7K in salary, $225.3K in stock awards and $15.7K in other compensation.

2014

In 2014, Jay R. Luly earned a total compensation of $2.5M as President and Chief Executive Officer at Enanta Pharmaceuticals.

Ranking3,604 out of 12,878
Percentile72.0%

Jay R. Luly's 2014 compensation ranked 3,604th out of 12,878 executive pay records tracked by us this year.

Luly earned more than 72.0% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking309 out of 1,310
Percentile76.4%

In the industry group of Drugs, Luly's pay ranked 309th out of 1,310 executive pay records tracked by us in 2014.

Luly earned more than 76.4% of executives in this group.

Bonus$262,455
Option Awards$1,755,908
Salary$489,382
Other$11,369
Total$2,519,114

Luly received $1.8M in option awards, which accounts for 69.70% of total compensation.

Luly also received $262.5K in bonus, $489.4K in salary and $11.4K in other compensation.

2013

In 2013, Jay R. Luly earned a total compensation of $1.6M as President and Chief Executive Officer at Enanta Pharmaceuticals.

Ranking4,501 out of 11,967
Percentile62.4%

Jay R. Luly's 2013 compensation ranked 4,501st out of 11,967 executive pay records tracked by us this year.

Luly earned more than 62.4% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking303 out of 1,095
Percentile72.3%

In the industry group of Drugs, Luly's pay ranked 303rd out of 1,095 executive pay records tracked by us in 2013.

Luly earned more than 72.3% of executives in this group.

Bonus$235,422
Option Awards$960,468
Salary$448,512
Other$4,439
Total$1,648,841

Luly received $960.5K in option awards, which accounts for 58.25% of total compensation.

Luly also received $235.4K in bonus, $448.5K in salary and $4.4K in other compensation.

2012

In 2012, Jay R. Luly earned a total compensation of $771.6K as President and Chief Executive Officer at Enanta Pharmaceuticals.

Ranking6,969 out of 10,963
Percentile36.4%

Jay R. Luly's 2012 compensation ranked 6,969th out of 10,963 executive pay records tracked by us this year.

Luly earned more than 36.4% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking443 out of 850
Percentile47.9%

In the industry group of Drugs, Luly's pay ranked 443rd out of 850 executive pay records tracked by us in 2012.

Luly earned more than 47.9% of executives in this group.

Bonus$213,914
Option Awards$145,736
Salary$407,482
Other$4,439
Total$771,571

Luly received $407.5K in salary, which accounts for 52.81% of total compensation.

Luly also received $213.9K in bonus, $145.7K in option awards and $4.4K in other compensation.

2011

In 2011, Jay R. Luly earned a total compensation of $610.2K as President and Chief Executive Officer at Enanta Pharmaceuticals.

Ranking7,105 out of 10,048
Percentile29.3%

Jay R. Luly's 2011 compensation ranked 7,105th out of 10,048 executive pay records tracked by us this year.

Luly earned more than 29.3% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking444 out of 705
Percentile37.0%

In the industry group of Drugs, Luly's pay ranked 444th out of 705 executive pay records tracked by us in 2011.

Luly earned more than 37.0% of executives in this group.

Bonus$173,491
Option Awards$35,208
Salary$397,110
Other$4,421
Total$610,230

Luly received $397.1K in salary, which accounts for 65.08% of total compensation.

Luly also received $173.5K in bonus, $35.2K in option awards and $4.4K in other compensation.